JTCS Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Minoru Tabata
Zain Khalpey
Lawrence H. Cohn
James D. Rawn
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tabata, M.
Right arrow Articles by Rawn, J. D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Tabata, M.
Right arrow Articles by Rawn, J. D.
Related Collections
Right arrow Cardiac - other
Right arrowRelated Article

J Thorac Cardiovasc Surg 2008;136:1510-1513
© 2008 The American Association for Thoracic Surgery


Acquired Cardiovascular Disease

Effect of preoperative statins in patients without coronary artery disease who undergo cardiac surgery

Minoru Tabata, MD, MPH*, Zain Khalpey, MD, PhD, Lawrence H. Cohn, MD, Fredrick Y. Chen, MD, PhD, R. Morton Bolman, III, MD, James D. Rawn, MD

Division of Cardiac Surgery, Brigham and Women's Hospital, Boston, Mass

Received for publication December 16, 2007; revisions received February 26, 2008; accepted for publication March 7, 2008.

* Address for reprints: Minoru Tabata, MD, MPH, Division of Cardiothoracic Surgery, Columbia University, College of Physicians and Surgeons, 177 Fort Washington Avenue, MHB 7-435, New York, NY 10032. (Email: mtabata{at}post.harvard.edu).

Objective: 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) have been shown to have pleiotropic effects in addition to their lipid-lowering properties. Some studies have shown the beneficial effect of preoperative statins on operative outcomes in coronary artery bypass grafting. However, the effect of preoperative statins in patients without coronary artery disease who undergo cardiac surgery remains poorly defined.

Methods: We performed a retrospective review of 1389 consecutive patients undergoing cardiac valve surgery between January of 2002 and December of 2005. Patients undergoing concomitant coronary artery bypass surgery and those with a history of myocardial infarction and coronary interventions were excluded. Of this cohort, 363 patients were receiving a statin preoperatively and 1026 patients were not. Propensity scores were constructed with patients' demographics, clinical data, and the year of procedure. Generalized estimating equations, including the propensity score as a covariate, were used to investigate whether preoperative statin use is associated with improved operative outcomes.

Results: The crude operative mortality rate was 0.8% and 2.3%, the incidence of stroke was 1.7% and 2.9%, and the incidence of perioperative myocardial infarction was 2.2% and 2.4% in the statin and non-statin groups, respectively. Generalized estimating equations showed that preoperative statin use is associated with lower mortality (odds ratio: 0.25, 95% confidential interval: 0.12–0.54). Preoperative statin use was not significantly associated with an incidence of stroke (odds ratio: 0.48, 95% confidential interval: 0.19–1.22) or perioperative myocardial infarction (odds ratio: 0.91, 95% confidential interval: 0.43–1.91) in this cohort.

Conclusion: Preoperative use of statins may improve operative outcomes in patients without coronary artery disease who undergo cardiac surgery.



Related Article

Does hypercholesterolemia improve operative outcomes in patients without coronary artery disease who undergo cardiac surgery?
Luca Mascitelli, Francesca Pezzetta, and Mark R. Goldstein
J. Thorac. Cardiovasc. Surg. 2009 138: 256. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Tabata
Reply to the Editor
J. Thorac. Cardiovasc. Surg., September 1, 2009; 138(3): 792 - 792.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
H. Takagi and T. Umemoto
A meta-analysis of controlled studies of preoperative statin therapy for prevention of postoperative mortality in cardiac surgery.
J. Thorac. Cardiovasc. Surg., September 1, 2009; 138(3): 790 - 791.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
L. Mascitelli, F. Pezzetta, and M. R. Goldstein
Does hypercholesterolemia improve operative outcomes in patients without coronary artery disease who undergo cardiac surgery?
J. Thorac. Cardiovasc. Surg., July 1, 2009; 138(1): 256 - 256.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Tabata
Reply to the Editor
J. Thorac. Cardiovasc. Surg., July 1, 2009; 138(1): 256 - 257.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 by The American Association for Thoracic Surgery.